Highly active antiretroviral therapy: Exhaustion of treatment options is a challenge that can be delayed
AUTOR(ES)
Murri, Rita
FONTE
BMJ Publishing Group Ltd.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=555616Documentos Relacionados
- Highly active antiretroviral therapy: Cardiovascular risk needs to be assessed before starting treatment
- Treatment exhaustion of highly active antiretroviral therapy (HAART) among individuals infected with HIV in the United Kingdom: multicentre cohort study
- Short-cycle structured intermittent treatment of chronic HIV infection with highly active antiretroviral therapy: Effects on virologic, immunologic, and toxicity parameters
- Treatment of primary HIV-1 infection with cyclosporin A coupled with highly active antiretroviral therapy
- Electroconvulsive therapy: Patients must be confident that evidence of efficacy is compelling